Investing.com - Ekso Bionics (NASDAQ: EKSO) reported first quarter EPS of $-0.220, $0.11 worse than the analyst estimate of $-0.110. Revenue for the quarter came in at $4.85M versus the consensus estimate of $4.8M.
Ekso Bionics's stock price closed at $2.100. It is up 40.000% in the last 3 months and up 40.940% in the last 12 months.
Ekso Bionics saw positive EPS revisions and negative EPS revisions in the last 90 days. See Ekso Bionics's stock price’s past reactions to earnings here.
According to InvestingPro, Ekso Bionics's Financial Health score is "fair performance".
Check out Ekso Bionics's recent earnings performance, and Ekso Bionics's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar